Literature DB >> 36233693

Clinical Applications of Photofunctionalization on Dental Implant Surfaces: A Narrative Review.

Li-Ching Chang1,2.   

Abstract

Dental implant therapy is a common clinical procedure for the restoration of missing teeth. Many methods have been used to promote osseointegration for successful implant therapy, including photofunctionalization (PhF), which is defined as the modification of titanium surfaces after ultraviolet treatment. It includes the alteration of the physicochemical properties and the enhancement of biological capabilities, which can alter the surface wettability and eliminate hydrocarbons from the implant surface by a biological aging process. PhF can also enhance cellular migration, attachment, and proliferation, thereby promoting osseointegration and coronal soft tissue seal. However, PhF did not overcome the dental implant challenge of oral cancer cases. It is necessary to have more clinical trials focused on complex implant cases and non-dental fields in the future.

Entities:  

Keywords:  bone–implant interface; dental implant; osseointegration; ultraviolet

Year:  2022        PMID: 36233693      PMCID: PMC9571244          DOI: 10.3390/jcm11195823

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.964


1. Introduction

Dental implant therapy is a common clinical procedure for the restoration of missing teeth. Further, the surface wettability of dental implant might affect osseointegration [1]. It was first found in 1997 that ultraviolet (UV) irradiation could induce superhydrophilicity in titanium dioxide (TiO2) because the surface oxygen vacancies at bridging sites result in the conversion of relevant Ti4+ sites to Ti3+ sites for more water adsorption [2,3]. In addition to applications in antifogging and self-cleaning materials, the concept was also used in dental implant treatment [3,4,5]. Photofunctionalization (PhF), first described in 2009, is defined as an overall phenomenon of titanium surface modification after UV treatment, including the alteration of physicochemical properties and the enhancement of biological capabilities [4,5]. UV radiation is categorized into UVA (wavelength λ = 320–400 nm), UVB (λ = 280–320 nm), and UVC (λ = 200–280 nm). The effects of PhF include the modification of the implant surface from hydrophobic to super-hydrophilic and the reversal of its biological aging [1,6,7,8]. Moreover, PhF could also decrease the amount of bacterial attachment/accumulation and maintain the antimicrobial surface in vitro [9,10,11]. The clinical application of PhF was first reported in 2013 and included seven implants in four implant complex cases utilizing PhF before implant placement [12]. Herein, we introduce the effects of PhF and its recent clinical applications. The aim of this article was to focus on clinical studies of PhF from January 2013 to June 2022. The digitally searched papers from PubMed used “photofunction” and “dental implant” as key words. After abstract review, there were two double-blind clinical trial studies, three prospective studies, four retrospective studies, and one case series in the present paper [12,13,14,15,16,17,18,19,20,21]. Furthermore, PhF applied in the spine surgery of 13 patients was included [22]. Except for some pre-clinical review papers on in vitro or animal studies, to my best knowledge, this paper is the first review focused on the clinical application of photofuctionalization [4,23,24,25].

2. In Vitro Studies

A brief summary of in vitro studies is shown in Table 1.
Table 1

The effect of photofunctionalization on dental implants in vitro.

AuthorMaterialMethodResults with UV Treatment
To Reverse the Biological Aging/Degradation of Implant Surface
Iwasa F et al. 2011 [6]Ti with micro-nano-hybrid topography vs. Ti withmicrotopography alone Rat bone-marrow-derived osteoblastsUV using a 15 W bacterial lamp for 48 h Stored for 8 weeks, then the PhF of a fresh, 3-day-old and 7-day-old UV-treated implant surface

Slower rate of the time-dependent degradation of titanium bioactivity after UV treatment in micro-nano-hybrid topography implant compared to that in microtopography alone

Tuna T et al. 2015 [7]Zirconia-based discs Smooth vs. rough surfacesUV using TheraBeam® Affiny for 15 min

To decrease carbon by 43–81%

To increase oxygen by 19–45% and zirconia by 9–41%

To change from hydrophobic to hydrophilic

No topographic change

Roy M et al. 2016 [26]Commercial osteoplant base and rapid titanium dental implantsUVC with TheraBeam® SuperOsseo for 12 min

To reverse the biological aging of titanium by reducing carbon contamination (up to 4-fold)

To reduce surface H2O

To increase TiOH with many -OH groups

To improve biologic results

No change in the topography of the surface

Roy M et al. 2017 [27]ZrO2 (Zr similar to titanium) UVC with TheraBeam® SuperOsseo for 12 min

To reduce carbon 3-fold

No change in crystalline structure

Arroyo-Lamas N et al. 2020 [28]Ti with Ti oxide surfaceUVC for 12 minMercury (Hg)-vapor (λ = 254 nm) vs.Light-emitting diodes (LEDs; λ = 278 nm)

To reduce the concentration of surface hydrocarbons (26~23.4 C at %)

To increase the concentration of O2 and Ti

Hg-vapor lamps could be replaced by LED-based technology

Roy M et al. 2021 [29]TiO2, ZrO2, polyether-ether-ketone (PEEK)UVC using TheraBeam® SuperOsseo for 12 min

To remove hydrocarbons (twofold in PEEK; threefold in TiO2 and ZrO2)

To decrease the harmful effect of the biological aging of the implant surface

Jaikumar RA et al. 2021 [30]Zirconia implantUV (λ = 254 nm) for 48 h

UV group vs. control group:

Oxygen concentration: 42.8% vs. 29.09%

carbon concentration: 34.34% vs. 45.41%

To enhance the surface topography and hydrophilicity

To decrease peri-implant stress distribution
Ohyama T et al. 2013 [31]3-dimensional finite element analysis of different lengths with various BICs (53.0% and 98.2%)BIC 98.2% as UV treatment

To diminish peri-implant stress by 50% (BIC 98.2% vs. 53.0%); 15% (implant length from 7 to 13 mm)

To improve the effective distribution of peri-implant stress rather than implant length

Similar results under oblique load

Ohyama T et al.2017 [32]Unique finite element analysis model with a 3D model (BIC: 53.0% or 98.2%)BIC 98.2% as UV treatmentVertical or oblique loading

To reduce stress on surrounding tissues

UV treatment vs. wider implants:

Greater effect in vertical loading

Less effect in oblique loading

Antimicrobial effect
Yamada Y et al.2014 [9]Wound pathogens such asStreptococcus pyogenes and Staphylococcus aureusTitanium discUVA (λ = 352 +/− 20 nm) orUVC (λ = 254 +/− 20 nm) with a mercury lamp for 48 h (500 J/cm2)

To decrease the amount of bacterial attachment and accumulation

To change wettability, as per the modification to a super hydrophilic surface

To reduce carbon content

(UV-C better than UV-A in the above items)

No change in topography

De Avila ED et al.2015 [10]Titanium discOral microbial community UVC using TheraBeam® SuperOsseo for 12 min

To create and maintain an antimicrobial surface

To change the bacterial community profile

To reduce bacterial attachment and biofilm formation

Jain S et al.2018 [11]Streptococcus sanguinisAnodized layer with a anatase phase Anodized layer with anatase and rutile phases15 W UVA(Philips; λ = 365 nm) or15 W UVC(Philips; λ = 254 nm)for 10 min

To reduce bacterial attachment by at least 20%

Achieve at least 50% killing efficacy by UVA in an anodized layer with an anatase phase

Achieve at least 50% killing efficacy by UVA or UVC in an anodized layer with anatase and rutile phases.

Different cell studies
Shen JW et al.2016 [33]MC3T3-E1 cellsAqueous medium (dH2O)UV using a 15 W bacterial lamp for 24 h5 groups of Ti implants(SLAnew, SLAold, modSLA, UV-SLA and UV-modSLA)

To remove hydrocarbon contamination on titanium stored in air or water

To increase cell attachment, proliferation, ALP activity, and osteocalcin release

Henningsen A et al.2018 [34]Murine osteoblasts Sandblasted and acid-etched titanium discsUVC using TheraBeam® SuperOsseo for 12 min

To increase the oxidation of the surface

To decrease the carbon on the surface

No change in surface structure

To promote osteoblast attachment and growth.

Ikeda T et al.2021 [35]Osteoblasts derived from rat bone marrowAcid-etched titanium disks UV treatment

To decrease bioactivity when the temperature fluctuates by ≥20 °C above or below room temperature (25 °C) (particularly toward lower temperatures), independent of the hydrophilicity/ hydrophobicity

To restore temperature-compromised bioactivity using UV treatment

Mehl C et al.2017 [36]Gingival fibroblastAbutments: zirconium dioxide and titanium alloyUVC using TheraBeam® SuperOsseo for 12 minArgon plasma Ultrasound disinfection

To increase cell adhesion on zirconium dioxide by UV, argon plasma, or ultrasound disinfection

To increase cell adhesion on a titanium alloy with ultrasound disinfection

Harder S et al.2019 [37]Human whole bloodTitanium with SLA surfaceUVC using TheraBeam® SuperOsseo for 12 min

To suppress the gene expression of IL 1β for 1–8 h

(TNF gene not significantly altered).

Nakhaei K et al.2020 [38]Human epithelial cellsPure titanium discsUVC using TheraBeam® SuperOsseo for 12 min

To remove carbon contamination by reducing C-C and C = O groups

To enhance the attachment, adhesion, and retention of epithelial cells on implants

Okubo T et al.2020 [39]Human epithelial cellsTitanium discs with a machined or polished surfaceUVC using TheraBeam SuperOsseo for 12 min

To remove the chemical contamination of the polished surface

To increase the number of attached epithelial cells on the implant

To increase the number of adherent cells after mechanical detachment

Razali M et al. 2021 [40]Human gingival keratinocytes and fibroblastsYttria-stabilized zirconia, alumina-toughened zirconia, and pure titanium abutmentsUVC using Therabeam® SuperOsseo for 12 min.

To improve the biological seal of the surrounding soft tissue peri-implant interface

Yttria-stabilized zirconia with the best biological seal among these materials

ALP: alkaline phosphatase; BIC: bone-to-implant contact; SLA: sandblasted acid-etched; Ti: titanium; UV: ultraviolet; UVA: ultraviolet A; UVC: ultraviolet C; 3D: three dimensions. PEEK: please to see material (polyether-ether-ketone). LEDs: Light-emitting diodes.

The water contact angle on the titanium surface was reduced to 0.5° after PhF; thus, the surface was changed from hydrophobic to super-hydrophilic [1,41]. The titanium implant surfaces had harmful and time-dependent degradation due to carbon contamination (hydrocarbons), which was defined as “the biological aging of titanium” [6,27,28]. Roy reported that titanium implant surfaces, as little as 4 weeks from production, are contaminated by atmospheric hydrocarbons [26]. The 4-week-old titanium implants required more osseointegration time than the newly prepared titanium implants by two-fold. The bone-to-implant contact (BIC) percentage on the 4-week-old surfaces was less than the BIC on the new surfaces (60% vs. 90%). Additionally, only 20% to 50% of the levels of recruitment, attachment, and proliferation of osteoblasts showed on the 4-week-old surface when compared with new surfaces [3]. The PhF could reduce the concentration of surface hydrocarbons on different implants by three- to four-fold, thus improving biologic results [26,27,29] and no change in the topography of implant surfaces [7,27,29]. Furthermore, PhF could increase the oxygen concentration of the zirconia implant surfaces and decrease carbon concentration [30]. There was increased protein adsorption, as well as the improved migration, attachment, and proliferation of osteoblasts on photofunctionalized surfaces in vitro [12,31,32]. In addition, UV treatment could restore the reduction in the bioactivity of titanium implants, which was adverse effect of temperature deviations when handling titanium materials [35]. With the exception of osteoblasts, the attachment of gingival fibroblasts or epithelial cells was also enhanced on UV-treated titanium and the zirconia abutment surface, which could enhance the soft tissue seal of the peri-implant interface [36,38,39,40]. In addition, the UV-photofunctionalization of instruments could prevent infection by restricting the growth of oral bacteria and biofilm and suppressing the proinflammatory gene expression of IL-1β [9,10,11,37].Therefore, PhF may be a useful and easy adjunctive method to improve osseointegration by utilizing a combination of these advantages. The average BIC is reported to be 45%, which is lower than the ideal 100% [12]. PhF could result in a super-hydrophilic implant surface, reversed the biological degradation of the implant surface, and optimized surface electrostatic charges [3,4,12]. Thus, PhF improves BIC by up to 98.2% and promotes osseointegration [3,4,5]. The bone morphogenesis around UV-irradiated titanium surfaces was known as “superosseointegration” [3,5,6]. Additionally, reduced stress on the surrounding tissues with improved stress distribution was found on UV-treated implants when compared with UV-untreated implants using a three-dimensional finite element analysis model, especially under vertical loading [31,32].

3. Preclinical Animal Studies

Additional hydrocarbons on titanium implant/instrument surfaces decreases bone-binding ability by aging [22]. However, PhF could promote osseointegration by reducing hydrocarbons [22,33]. Shen reported that UV PhF eliminated hydrocarbon contamination with resultant enhanced BIC and osseointegration in a rabbit model [42]. This increase in BIC was found in rat, rabbit, and dog models [1,43,44,45,46,47,48,49,50]. However, there were no significant differences in BIC and implant stability quotient (ISQ) between the UV treatment and control group 9 months after implant placement in the jaw bone of mini-pigs [51]. Except for titanium, the BIC was also enhanced in zirconia-based material by 3 to 7-fold in smooth surfaces and by 1.4 to 1.7-fold in rough surfaces [43]. The osseointegration of custom-made or commercial dental implants was accelerated by PhF in different animal models; in other words, an earlier osseointegration was achieved by UV treatment [5,8,34,49,51]. The biological enhancing effect remained even after 12 weeks of healing in a rabbit model [52]. A 2.2~2.3-fold increase in the strength of osseointegration was found in normal rats, and the genetically modified rats (close to human diabetes) showed a 1.8 to 3-fold increase after using UV treatment (TheraBeam Affiny device) for 15 min [53,54]. The strengtth of osseointegration in the aged rats was enhanced by 40% after UV treatment (TheraBeam SuperOsseo device) for 12 min [55]. Moreover, bone-implant integration after PhF was 80% higher than that of the control titanium implants in ovariectomized rats (close to osteoporosis) [41]. When implants were subjected to constant lateral force during healing, an increased implant success rate was seen in photofunctionalized surface group as compared with the control group (100% vs. 28.6% respectively) in a rat study [56]. In addition, PhF increased the orthodontic mini-screw’s resistance against tipping force by 1.5~1.7-fold and resulted in less displacement under a lateral tipping force in rats [57,58]. Therefore, it is impossible to gain more anchorage of orthodontic mini-screws clinically by using UV treatment. Except for the PhF with commercial UV machines, the use of a bacterial UV bench lamp (wavelength of 254 nm) for 48 h also increased the volume of cortical-like tissue in the coronal region in a rabbit study [9]. The early osseointegration of aged titanium implants in a dog model could be enhanced by ultraviolet-C light photofunctionalization. However, the effect was independent on UVC exposure within a range from ten minutes to one hour [59]. Therefore, the UV treatment time using a bench lamp is too long for clinical use when compared with UV machines that require 12 or 15 min. Finally, a summary of the preclinical animal studies is shown in Table 2.
Table 2

Preclinical animal studies of photofunctionization.

AuthorMaterial UV LightResults with UV Treatment
Rat model
Aita H et al.2009 [5]Machined and acid-etched Ti In 9 rats (8 weeks old) UVA/UVC for variable time up to 48 h

To enhance osteoconductive capacity

To accelerate implant fixation 4-fold

Ikeda T et al.2014 [53]Nanofeatured TiFemurs of 6 rats (8 weeks old) UV-T for 15 min using TheraBeam Affiny

To improve the strength of osseointegration by a push-in test

(2.2-fold in week 2 and 2.3-fold in week 4 of healing)

Sugita Y et al. 2014 [54]Ti femurs of 10 genetically modified rats (phenotype close to human type 2 diabetes; 10 weeks old)UV for 15 min using TheraBeam Affiny

To increase the strength of osseointegration (1.8-fold in week 2 and 3-fold in week 4 of healing) in a rat model of type 2 diabetes

Minamikawa H et al.2014 [8]Ti6Al4V (smooth or rough surface)Femurs of 6 rats (8 weeks old)UV-T for 15 min using TheraBeam Affiny

To convert the Ti6Al4V surface from hydrophobic to super-hydrophilic (however, the conversion to hydrophobic takes 4 weeks)

To improve the strength of the bone–implant integration of both surfaces (UV treatment on a smooth surface > no treatment on a rough surface)

Tabuchi M et al.2015 [57]Ti-6Al-4V mini-screw Femurs of 6 rats(8 weeks old)UV for 12 min using TheraBeam SuperOsseo device

To change from hydrophobic to super-hydrophilic

To increase resistance against the tipping force by 1.5~1.7-fold

To gain a strong elemental peak of calcium and phosphorus

Tabuchi M et al.2015 [58]Ti-6Al-4V mini-screw Femurs of 6 rats(8 weeks old)UV for 12 min using TheraBeam SuperOsseo

To improve anchoring capability

Less displacement under lateral tipping force

More intact and contiguous regenerated bone tissue

Brezavscek M et al.2016 [43] Zirconia-based discFemurs of 88 rats(8 weeks old)Push-in test (48 rats)UV for 15 min using TheraBeam Affiny

To increase push-in values at Week 2 by 2.1–2.8-fold and at Week 4 by 1.7–2.0 fold

To increase the BIC on a smooth surface by 3~7-fold and on a rough surface by 1.4~1.7-fold

To enhance the strength of the bone–implant interface by 2-fold (40 rats)

Ishijima M et al.2016 [55]Ti mini-implants Femur of 6 aged rats(15 months old)UV for 12 min using TheraBeam SuperOsseo

To enhance the strength of osseointegration by 40% in aged rats

Strong elemental peaks of calcium and phosphorus

Hirota M et al.2017 [44]Acid-etched Ti implants(1 × 4 mm) and Ti meshFemurs of 20 rats(8 weeks old)Half of implants in 2 mm defect, half exposed UV for 12 min using TheraBeam SuperOsseo

To enhance vertical ridge augmentation and bone–implant contact

To increase the strength of osseointegration (3-fold)

To enhance the closure of the bone–implant gap

Soltanzadeh P et al.2017 [56]Ti implants Femurs of 7 rats(8 weeks old)0.46 N of constant lateral force UV for 12 min using TheraBeam SuperOsseo

To increase the success rate (100% vs. 28.6%)

To increase the strength of osseointegration (2.4-fold)

To decrease the implant title degrees (0.5-fold)

Taniyama T et al.2020 [41]Ti implants (1 × 2 mm)Femurs of sham-operated vs. ovariectomized rats (each n = 8; 12 weeks old)Rat osteoporosis model Push-in testUV for 12 min using TheraBeam SuperOsseo

Titanium with vs. without UV treatment: Contact angle of H2O: </=5 degrees vs. >/=80 degrees

To enhance bone–implant integration in ovariectomized rats (80% higher than control titanium)

To increase the push-in value in both groups by 50–70%

Rabbit model
Sawase T et al.2008 [1]Ti implant with the anatase form of a TiO2 surfaceTibia of 6 rabbits(28–36 weeks old)UV for 24 h

To improve initial cell reactions

To enhance early bone formation by increasing BIC

Jimbo R et al.2011 [60]Fluoride-modified TiUnite implants Tibial metaphyses of 12 rabbits (28–36 weeks old)UV (352 nm) for 24 h

To enhance BIC and bone apposition during early stages of osseointegration (2 and 6 weeks)

Hayashi M et al.2014 [52]TiO2 powder spin-coated onto pure titanium disctibiae of 9 rabbitsUV (352 nm, 6 W) for 24 h

To upregulate gene expression (ALP, RUNX-2, and IL-10)

To continue the biologically enhancing effect even after 12 weeks of healing time

Yamazaki M et al.2015 [61]Acid-etched pure titanium screws Femur of 20 rabbits(16 weeks old)UVC (3 mW/cm2) for 48 h using a 15 W bactericidal UV bench lamp (254 nm)

To gain a higher density of cells, as well as thicker and longer bone tissue attachments

To increase the volume of cortical-like tissue in the coronal region

Shen J et al.2016 [42]Ti implants (4 × 8 mm)Tibial metaphyses and femoral condyles of 40 rabbits 32 implants × 5 groups:SLAnew, SLAold, modSLA, UV-SLA, and UV-modSLA UVA/UVC for 24 h

To eliminate hydrocarbon contamination

To enhance bone-to-implant contact (interfacial strength) and osseointegration

Kim HS et al.2017 [49]Commercial Ti implants(4 × 6 mm)Tibia of 12 rabbits(>12 weeks old)ALN on titanium surfaceUV at 189.4 nm and 253.7 nm of wavelength for 2 h using UV-Cleaner

To increase per-implant bone formation and osseointegration

Highest bone–implant contact in the UV+/ALN+ group

Lee JB et al.2019 [50]Machined SLA surface Ti implantsTibia of 4 rabbits (12 and 16 weeks old)UVC for 48 h

Higher bone-to-implant contact ratio at 10 days

To gain earlier osseointegration in a machined surface implant after UV treatment than in an SLA surface implant

Sanchez-Perez A et al.2020 [46]20 commercial Titanium implants (3.75 × 8 mm)5 rabbits (3–3.5 kgs)UVC-lamp (254 nm; 6 W)at a distance of 15 cm for 15 min

Did not improve the percentage of BIC at 8 weeks

More homogenous BIC values in the UV group

Yin C et al. 2022 [62]3D-printed porous Ti6Al4V scaffolds in a dark place for 4 weeks Bilateral femur condyles of 27 mature male New Zealand rabbitsA irradiation cube: >2 MW/cm2 (270 nm) and 30 MW/cm2 (365 nm) for 15 min

To enhance hydrophilicity, cytocompatibility, and alkaline phosphatase activity, while preserving their original mechanical properties in vitro

To promote bone ingrowth, the bone–implant contact ratio, and the mineralized/osteoid bone ratio in vivo

Dog model
Hirakawa Y et al.2013 [48]Ti implants with TiO2 surface Mandible of 6 beagle dogsPlasma source ion implantation methodUVA (352 nm) for 24 h

To improve serum fibronectin attachment

To increase BIC after 2 weeks healing (42.7% vs. 28.4% in control)

To accelerate early osseointegration by a combination of plasma fibronectin and plasma source ion implantation

Pyo SW et al.2013 [47]Commercial Ti implants Both jaws of 4 dogs(72–96 weeks old) UV for 15 min using TheraBeam Affiny

To convert an implant surface from hydrophobic to super-hydrophilic

To increase removal torque by 50% and BIC

To promote interfacial bone deposition and marginal bone seal

Kim MY et al.2016 [63]Ti implantsMandibular premolars of 4 female beagle dogs(24 weeks old)2 as control vs. 2 as UV UV for 15 min using TheraBeam Affiny

To gain better osseointegration

To increase bone-to-implant contact (BIC) and new bone formation

Huang Y et al.2022 [59]Aged Ti-implant Mandibular premolars of 8 male beagle dogs12 as controlUVC for 1/6 h (12)UVC for 1/2 h (12)UVC for 1 h (12)

There were significantly higher BV/TV and bone–implant contact at 4 weeks; however, there were no significant differences at 12 weeks.

The effect was independent on the UV-C duration.

Minipig model
Mehl C et al.2018 [51]48 titanium implants Both jaws of 3 mini-pigsUVC for 48 h

To attain higher earlier osseointegration

No significant differences in bone–implant contact (BIC) and implant stability quotient (ISQ) in 9 months

ALN: alendronate; BIC: bone-to implant contact; BV/TV: trabecular bone volume to total volume fraction; IL-10: interleukin-10; ISQ: implant stability quotients; RUNX-2: runt-related transcription factors 2; Ti: titanium; UV: ultraviolet; UVA: ultraviolet A; UVC: ultraviolet C.

4. Clinical Studies

Ten clinical papers were associated with dental implant therapy using photofunctionalization. Most papers (7/10) were from the Ogawa study group in Japan [12,13,14,15,16,17,18]. These papers are summarized in Table 3.
Table 3

Clinical studies of dental implant therapy using photofunctionization.

AuthorStudy TypeMaterial and MethodResults with UV Treatment
I-1. Dentistry
Ogawa T. Study Group (Japan)
Funato A et al.2013 [12]Case series

7 implants (3i Biomet, Certain) in the compromised bone of four patients

UV machine (TheraBeam Affiny; Ushio Inc., Tokyo, Japan): UV treatment for 15 min

Complex cases: fresh extraction socket, sinus elevation, vertical ridge augmentation, and the immediate replacement of failing implant

ISQs from 48–75 at placement to 68–81 at loading

To gain more ISQ between implant placement and loading in cases with lower primary stability

To increase or to maintain marginal bone level at one year after loading

PhF enhanced OSI (increased ISQ per month) in complex cases

PhF shortened osseointegration time

Funato A et al.2013 [13]Retrospective study

168 implants in 70 patients (with UV treatment) vs. 222 implants in 95 patients (without UV treatment)

UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min

To shorten healing time before loading: 3.2 months vs. 6.5 months

To promote “OSI” in different primary stability subgroups:

“2.0–8.7” vs.”1.8–2.8”

Similar implant survival rate: 97.6% vs. 96.3%

PhF allowed for a faster loading protocol without compromising the implant success rate

Suzuki S et al.2013 [14]Prospective study

33 implants (NobleReplace, TiUnite) in the maxilla of 7 patients

UV machine

(TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min

To increase ISQ in UV treatment groups: eliminating stability dip, 78.0 at 6 weeks vs. 66.1 at

2~6 months in “literature as-received implants”

To promote OSI in UV treatment groups:

6.3 in “initial ISQ from 65 to 70” and 3.1 in “initial ISQ from 70 to 75” vs. −3.0 to 1.17(average: -0.10) in “literature as-received implants”

PhF accelerated and enhanced the osseointegration of dental implants

Kitajima H et al.2016 [15]Retrospective study

55 implants (3i Biomet, Certain) in 38 patients with ISQs < 60 at placement

UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min

190.9% implants in complex cases: GBR, sinus lift or fresh extraction sockets; 9.1% in regular cases

Implant success rate: 98.2% after 2–3 years follow-up

To increase in ISQs from 50.4 +/− 7.7 at placement to 74.3 +/− 5.7 at Stage II surgery; average healing time 7.1 +/− 2.1 months

OSI (OSI as “ISQ at Stage II–ISQ at placement/healing time”) of low initial-stability implants (ISQs < 55):

3.9–4.7 in the UV group vs. 0.36–2.8 in the as-received group

PhF was more effective for implants with lower primary stability

Hirota M et al.2016 [16]Retrospective case-control study

49 implants (Branemark MKIII TiUnite) in 7 patients; 24 as-received and 25 with UV treatment

UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min

Complex cases: GBR, sinus lift, fresh extraction sockets

To accelerate OSI both for regular and complex cases, especially more pronounced in cases with poor quality bone and complex cases

To increase final ISQ at Stage II in the UV group regardless of primary stability and innate bone support at implant placement

PhF was a stronger determinant of implant stability than other factors

Hirota M et al.2018 [17]Retrospective study

563 implants in 219 patients

Bone quality classification with CT Hounsfield unit (HU): D1~D4

UV machine (TheraBeam Affiny; Ushio Inc., Tokyo, Japan): UV treatment for 15 min

D1: >1250 HU; D2: 750–1250 HU; D3: 375–750 HU; D4: 150–375 HU

Early implant failure rate: subjects with UV treatment vs. subjects without UV treatment: 1.3% vs. 4.3%

To reduce the early implant failure rate after UV treatment

Hirota M et al.2020 [18]Prospective study

70 implants in 16 patients for follow-up after 7 years, including regular cases, complex cases, and cancer-related patients

Bone quality classification with CT Hounsfield unit (HU): D1~D5

CT, bone quantity: A~E

UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): UV treatment for 15 min, then cleaning ozone for 5 min

Regular (no site development or cancer): 30 implants into analysis + 4 implants in sleep;

Complex (GBR, sinus lift, fresh extraction sockets): 21 implants;

Cancer (cancer-related resection +/− radiation): 15 implants

Success rate in regular cases, complex cases, and cancer-related patients: 100%, 100% and 22.2%

Did not overcome the challenges of a pathophysiologically compromised oral condition

I-2. Other study groups
Puisys A et al.2020 (German) [19]Triple-blinded, split-mouth, randomized controlled clinical trial

360 implants in 180 patients;

180 (UV; 71 in maxilla, 109 in mandible) vs. 180 (control; 71 in maxilla, 109 in mandible)

Placement; Groups 1~6 (weeks 1, 2, 3, 4, 6, and 8)

UV device (TheraBeam SuperOsseo; Ushio Inc., Sazuchi Bessho-cho, Himejij, Hyogo, Japan): for 12 min

wavelength: 180–300 nm

To increase the RT value (indirect information of BIC)

Significant difference in the RT value between UV and control: in groups 2, 3, 4, and 6.

To improve healing and implant stability, especially in the early phase

To increase the speed of osseointegration

Choi B et al.2021 (Korea) [20]Parallel-designed randomized double-blinded clinical trial

57 implants in the posterior maxilla of 34 patients; 29 (UV) vs. 28 (control)

CBCT grayscale value:

>500: bone quality group II; 300~500: group III<300: group IV UV machine (TheraBeam Affiny; Ushio Inc. Tokyo, Japan): for 15 min

Group III: significant difference in ISQ at 4 weeks and 4 months

Group II: significantly less bone loss in the UV-treatment group at 4 weeks

Others: no significant difference between the UV-treatment and the control group

To increase initial stability in posterior maxilla with poor bone density

To allow a faster loading protocol

Shah SA et al.2021 (India) [21] Randomized controlled trial

Immediate implants in the anterior maxilla of 90 patients

Control group and implants pretreated with platelet-rich plasma (PRP group) or photofunctionalization (PF group)

UV radiation of wavelength 253.7 nm in an ultraviolet ray chamber (SK Dent) for 20 min

Pretreatment with PF or PRP:

statistically significant difference only in implant stability but not in other parameters (including marginal bone loss, pink/white aesthetic score and success/survival rate)

II. Orthopedics
Tominaga H et al.2019 [22]Prospective study

13 patients underwent lumbar fusion

Prospace intervertebral cage (B-Braun Company, Germany)

UV using a low-pressure mercury lamp (TheraBeam Affiny; Ushio Inc. Himeji, Japan): for 15 min

wavelength of 254 nm and 9.5 mW/cm2

To change the surface hydrophilic from hydrophobic

To decrease the amount of carbon attached on the cage

No significant difference between the degree of osteosclerosis between titanium cages with UV and without UV treatment

Note: UV photofunctionalization in spine surgery is questionable.

BIC: bone-to-implant contact; CBCT: cone-beam computed tomography; CT: computed tomography; ISQ: implant stability quotients; HU: Hounsfield unit; OSI, osseointegration speed index; PhF, photofunctionalization; RT, removal torque; UV, ultraviolet.

The first clinical report in 2013 by Funato et al. revealed that the ISQs for seven implants placed in compromised bone after PhF for 15 min increased from a range of 48~75 at placement to 68~81 at loading [12]. Funato’s further retrospective study showed that PhF could shorten healing time from 6.6 months to 3.2 months before loading when compared with the control group; however, the implant survival rates of both groups were similar [13]. This means that PhF would enhance the dental implant osseointegration speed index (OSI) [12,13]. In addition, the same result was also found in Suzuki’s prospective research [14]. Moreover, the implant stability dip was eliminated by PhF; especially implants with less primary stability could obtain more ISQs gain using a TheraBeam Affiny machine [12,14,15]. UV treatment has chemical and biological effects on the osseous–implant interface, and PhF for as little as 15 min could enhance BIC and promote osseointegration [64]. In comparison with regular cases, PhF was more effective in complex cases, including cases with ridge augmentation, sinus elevation, and immediate implant [16]. PhF is a stronger determinant of implant stability than the other patient-related and implant-site-related factors [16]; thus, PhF results in a lower early failure rate than that in the non-UV treatment group (1.3% vs. 4.3%) in a large retrospective study [17]. However, PhF still did not overcome the pathophysiological condition of cancer-related complex cases with bone resection, segmental defect, or radiation, in which the implant survival rate was only 22.2% [18]. In addition to Japan’s studies, which used a TheraBeam Affiny (Ushio Inc., Tokyo, Japan) for 15 min, a recent Korean clinical trial also used the same UV machine [29]. The UV light of the TheraBeam Affiny was delivered as a mixture of spectra via a single source UV lamp at λ = 360 nm and λ = 250 nm [7]. The study focused on the effect of PhF on implants, which was placed in different groups of the posterior maxilla according to CBCT (cone-beam computed tomography) grayscale for bone density [29]. The results showed that PhF could increase initial implant stability in posterior maxilla, thus allowing a faster loading protocol [29]. Another UV device, the TheraBeam SuperOsseo (Ushio Inc., Himeji, Japan) was used in a clinical trial from Germany, which used the implant removal torque value as an indirect reference of BIC in 360 implants of 180 patients [19]. The UV light of the TheraBeam SuperOsseo was delivered as a mixture of spectra; the intensity was 0.05 mW/cm2 at λ = 360 nm and 2 mW/cm2 at λ = 250 nm [34]. The finding from this research showed that PhF improved early-phase healing and stability and promoted the speed of osseointegration [19]. Shah reported that the pretreatment of dental implants with UV light revealed a statistically significant difference only in implant stability but not in other parameters, including mean marginal bone loss, pink/ white aesthetic score, and success/survival rate [21]. In the spine surgery of 13 patients, the result showed no significance in osteosclerosis between UV-treated and UV-untreated cages in lumbar fusion [22]. The ratio of the carbon attachment of titanium cages (20% at one year) in orthopedics was less than that in dental titanium instruments (60% at 4 weeks); thus, the effect of the UV photofunctionalization of titanium instrumentation in spine surgery was questionable [22]. However, UV-treatment could improv the osseointegration of aged 3D-printed porous Ti6Al4V scaffolds in the femur condyles of rabbits in a recent study [62]. It is possible that photofunctionalization has a positive effect in the further application of orthopedics.

5. Discussion

The mechanisms behind the enhanced osseointegration of dental implants after photofunctionalization are due to improving hydrophilicity and eliminating hydrocarbon contamination on the implant surface [25]. The UVA (wavelength range from 320 to 400 nm) and UVC (wavelength range from 200 to 280 nm) irradiation could result in hydrophilicity and the nano-scale modification of the titanium surface [25,65]. However, the vital mechanism behind excellent osseointegration might be because of carbon removal from the titanium surface by UVC [4,5]. In addition to antibacterial effects, UV activation would enhance the adsorption of plasma proteins of human body and improve osteogenic cell attachment, spreading, and proliferation [11,25,60]. Thus, it is possible to shorten the dental implant treatment time. There is a conspicuous bacterial colonization on implants only 30 min after implant insertion [66,67], which may be prevented by UV-photofunctionalization restricting the growth of oral bacteria and biofilm [9,10,11]. Peri-implant-diseases-associated biofilms would affect the long-term outcome of dental implants. The microbial composition between periodontitis and peri-implantitis are similar; however, dental implants are more susceptible to oral infections due to anatomic and physiologic differences from natural teeth [67,68]. In addition, the peri-implant tissue response, including pro-inflammatory state, is influenced by transmucosal abutment geometry and surface [68]. Thus, the positive effect of photofunctionalization for the attachment of gingival fibroblasts or epithelial cells on implant abutment surface, which may decrease the severity of peri-implant infection [36,38,39,40]. There were some disadvantages in pre-clinical studies, which resulted in a risk of bias [23,24]. The quality assessment revealed that no animal study revealed a low risk of bias for all domains [23,24]. However, photofunctionalization still showed a benefit in the initial phase of osseointegration in different animal models [24]. The limitations in the clinical studies included differences in the age of patients, photofunctionalization protocol, experience of users, and follow-up period. Except for one German study, other studies were performed in Asia. The publication bias in the clinical studies would limit the significance of this contribution to implant dentistry. Thus, it is necessary to prove a positive effect in Western people through more studies. Photofunctionalization could overcome the challenge of complex dental implant cases, except for cancer-related cases with bone resection, segmental defect, or radiation [18]. Changing the photofunctionalization protocol (UV treatment for 15 min, then cleaning ozone for 5 min) may have an advantage in these complicated cases.

6. Conclusions

Many methods have been used to promote osseointegration for successful implant therapy, including photofunctionalization. UV photofunctionalization can change the surface wettability and eliminate the hydrocarbons that are generated by aging on the implant surface. Photofunctionalization can also enhance cell migration, attachment, and proliferation to promote osseointegration and coronal soft tissue seal. However, photofunctionalization did not overcome the cancer-related pathological condition and had little effect on the resistance to oblique forces. Moreover, the clinical assistance of photofunctionalization is still limited by the field of dental implants. To use the results, therefore, it is necessary to have more clinical trials focused on complex implant cases and non-dental fields in the future.
  66 in total

1.  Photofunctionalized dental implants: a case series in compromised bone.

Authors:  Akiyoshi Funato; Takahiro Ogawa
Journal:  Int J Oral Maxillofac Implants       Date:  2013 Nov-Dec       Impact factor: 2.804

2.  Photofunctionalization and non-thermal plasma activation of titanium surfaces.

Authors:  Anders Henningsen; Ralf Smeets; Philip Hartjen; Oliver Heinrich; Roman Heuberger; Max Heiland; Clarissa Precht; Claudio Cacaci
Journal:  Clin Oral Investig       Date:  2017-07-20       Impact factor: 3.573

3.  High bone-implant contact achieved by photofunctionalization to reduce periimplant stress: a three-dimensional finite element analysis.

Authors:  Tetsuo Ohyama; Tendo Uchida; Norio Shibuya; Shinya Nakabayashi; Tomohiko Ishigami; Takahiro Ogawa
Journal:  Implant Dent       Date:  2013-02       Impact factor: 2.454

4.  The Use of Photofunctionalized Implants for Low or Extremely Low Primary Stability Cases.

Authors:  Hajime Kitajima; Takahiro Ogawa
Journal:  Int J Oral Maxillofac Implants       Date:  2016 Mar-Apr       Impact factor: 2.804

5.  Impact of Cleaning Procedures on Adhesion of Living Cells to Three Abutment Materials.

Authors:  Christian Mehl; Matthias Kern; Anna Zimmermann; Sönke Harder; Steven Huth; Christine Selhuber-Unkel
Journal:  Int J Oral Maxillofac Implants       Date:  2017 Sep/Oct       Impact factor: 2.804

6.  Photocatalytically induced hydrophilicity influences bone remodelling at longer healing periods: a rabbit study.

Authors:  M Hayashi; R Jimbo; Y Xue; K Mustafa; M Andersson; A Wennerberg
Journal:  Clin Oral Implants Res       Date:  2013-02-26       Impact factor: 5.977

7.  The Effect of UV Treatment on the Osteoconductive Capacity of Zirconia-Based Materials.

Authors:  Miha Brezavšček; Ahmed Fawzy; Maria Bächle; Taskin Tuna; Jens Fischer; Wael Att
Journal:  Materials (Basel)       Date:  2016-11-24       Impact factor: 3.623

8.  An In-Vitro Analysis of Peri-Implant Mucosal Seal Following Photofunctionalization of Zirconia Abutment Materials.

Authors:  Masfueh Razali; Wei Cheong Ngeow; Ros Anita Omar; Wen Lin Chai
Journal:  Biomedicines       Date:  2021-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.